These findings suggested WWP2 played a role in ALL development as well as growth and apoptosis of ALL, and displayed a regulatory pathway of PARP1, which provide a new potential therapeutic target for the treatment of ALL. The gene discussed is WWP2; the disease is acute lymphoblastic leukemia.